Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Healthwell Acquisition C... (HWEL)

Healthwell Acquisition Corporation I
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HWEL
DateTimeSourceHeadlineSymbolCompany
18/11/202302:29Business WireHealthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to LiquidateNASDAQ:HWELHealthwell Acquisition Corporation I
03/11/202323:00Business WireHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.NASDAQ:HWELHealthwell Acquisition Corporation I
24/10/202304:55Business WireHealthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
17/10/202311:00Business WireHealthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
04/10/202313:00Business WireStarton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
13/09/202321:05Business WireStarton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
10/07/202312:00Business WireStarton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
23/06/202322:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202315:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202315:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
12/06/202321:44Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
12/06/202321:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
12/06/202321:30Business WireStarton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
07/06/202315:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202313:41Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202313:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202313:00Business WireStarton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare ConferenceNASDAQ:HWELHealthwell Acquisition Corporation I
18/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
15/05/202322:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
15/05/202322:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
15/05/202321:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
03/05/202322:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202312:21Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202312:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202312:00Business WireStarton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer TreatmentsNASDAQ:HWELHealthwell Acquisition Corporation I
23/03/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202322:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202311:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
13/02/202321:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
10/02/202322:02Edgar (US Regulatory)

NASDAQ:HWELHealthwell Acquisition Corporation I
 Showing the most relevant articles for your search:NASDAQ:HWEL